715 related articles for article (PubMed ID: 24310455)
21. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
[TBL] [Abstract][Full Text] [Related]
22. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis.
Sombekke MH; Wattjes MP; Balk LJ; Nielsen JM; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
Neurology; 2013 Jan; 80(1):69-75. PubMed ID: 23243070
[TBL] [Abstract][Full Text] [Related]
23. Tumor-like multiple sclerosis.
Basić Kes V; Cesarik M; Corić L; Zavoreo I; Rotim K; Beros V; Pazanin L; Drnasin S; Demarin V
Acta Clin Croat; 2012 Mar; 51(1):113-6. PubMed ID: 22920013
[TBL] [Abstract][Full Text] [Related]
24. [Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature].
Sierra-Marcos A; Mitjana R; Castilló J; Edo MC; Horga-Hernández A; Tintoré M; Río-Izquierdo J; Auger-Acosta C; Rovira A; Montalban X
Rev Neurol; 2010 Aug; 51(3):129-34. PubMed ID: 20645263
[TBL] [Abstract][Full Text] [Related]
25. The role of MRI in the diagnosis of multiple sclerosis.
Traboulsee AL; Li DK
Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event.
Gout O; Bouchareine A; Moulignier A; Deschamps R; Papeix C; Gorochov G; Héran F; Bastuji-Garin S
Mult Scler; 2011 Feb; 17(2):164-72. PubMed ID: 20965960
[TBL] [Abstract][Full Text] [Related]
27. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases].
Pou Serradell A; Roquer González J; Perich Alsina X
Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729
[TBL] [Abstract][Full Text] [Related]
28. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
[TBL] [Abstract][Full Text] [Related]
29. T2 hypointense rims and ring-enhancing lesions in MS.
Llufriu S; Pujol T; Blanco Y; Hankiewicz K; Squarcia M; Berenguer J; Villoslada P; Graus F; Saiz A
Mult Scler; 2010 Nov; 16(11):1317-25. PubMed ID: 20685762
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
[TBL] [Abstract][Full Text] [Related]
32. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
[TBL] [Abstract][Full Text] [Related]
33. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Sbardella E; Tomassini V; Stromillo ML; Filippini N; Battaglini M; Ruggieri S; Ausili Cefaro L; Raz E; Gasperini C; Sormani MP; Pantano P; Pozzilli C; De Stefano N
Mult Scler; 2011 Dec; 17(12):1432-40. PubMed ID: 21729978
[TBL] [Abstract][Full Text] [Related]
34. [Young-onset multiple sclerosis].
Silva A; Sá MJ
Rev Neurol; 1999 Jun 1-15; 28(11):1036-40. PubMed ID: 10390767
[TBL] [Abstract][Full Text] [Related]
35. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.
Atzori M; Battistella PA; Perini P; Calabrese M; Fontanin M; Laverda AM; Suppiej A; Drigo P; Grossi P; Rinaldi L; Gallo P
Mult Scler; 2009 Mar; 15(3):363-70. PubMed ID: 18987105
[TBL] [Abstract][Full Text] [Related]
36. [Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions].
Navarro S; Mondéjar-Marín B; Pedrosa-Guerrero A; Pérez-Molina I; Garrido-Robres JA; Alvarez-Tejerina A
Rev Neurol; 2005 Nov 16-30; 41(10):601-3. PubMed ID: 16288423
[TBL] [Abstract][Full Text] [Related]
37. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
38. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Marques IB; Matias F; Silva ED; Cunha L; Sousa L
J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563
[TBL] [Abstract][Full Text] [Related]
39. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ
J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950
[TBL] [Abstract][Full Text] [Related]
40. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
